Telangana’s startup engine, T-Hub has signed a memorandum of understanding (MoU) with pharmaceutical major Novartis Healthcare Private Limited to create and execute joint programmes that will benefit health tech startups from across segments.
As part of the MoU, Novartis will be working with T-Hub to develop plans and programmes that will help heath tech, health care and pharmaceutical startups to scale and grow. As part of the initiative, research and development experts from Novartis will mentor and guide startups. The MoU will help foster a close relationship in these areas while contributing towards the building of a thriving ecosystem in Hyderabad.
Speaking about the partnership, T-Hub CEO Jay Krishnan said, “Novartis will bring great value to the ecosystem and health tech startups will be greatly benefited. With health tech being one of our prime sectors, we are working towards ensuring that startups associated with T-Hub are well mentored and guided.”
Headquartered in Basel, Switzerland, Novartis has a significant footprint in India with a strong base in Hyderabad through its Global Drug Development and Business Services Center.
Novartis Global Drug Development India Head Subodh Deshmukh said, “We are excited about this potential partnership with T-Hub and its allied startups driving innovation in the healthcare space.”